Clinical Trial Update: HEME Home Transfusion Program [NA]

View source ↗

Summary

Clinical trial update indicates that the HEME Home Transfusion Program is currently recruiting for hematologic conditions including leukemia, multiple myeloma, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Diseases
• Hematologic Malignancy
• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Leukemia, Myeloma | NA | Status: RECRUITING